Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host diseaseFRONTIERS IN IMMUNOLOGYIF5.92022-09-148OAAI
Teriflunomide Modulates Vascular Permeability and Microglial Activation after Experimental Traumatic Brain InjuryMOLECULAR THERAPYIF122018-09-0127OAAI
Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury前列腺素E2指示间充质干细胞在实验性创伤性脑损伤中的治疗作用Stem CellsIF3.62017-03-1687OAAI
Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular FractionSTEM CELLS TRANSLATIONAL MEDICINEIF4.92017-01-0692OAAI
Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain InjurySTEM CELLS TRANSLATIONAL MEDICINEIF4.92015-11-1960OA
MSCs and hyaluronan: Sticking together for new therapeutic potential?INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGYIF2.82014-10-0125PREAI
Differential MSC activation leads to distinct mononuclear leukocyte binding mechanismsSCIENTIFIC REPORTSIF3.92014-04-0253OAAI
Intravenous multipotent adult progenitor cell therapy as a novel treatment in traumatic brain injury: modulation of the inflammatory responseJOURNAL OF THE AMERICAN COLLEGE OF SURGEONSIF3.42013-09-010PREAI
TSG-6 Produced by hMSCs Delays the Onset of Autoimmune Diabetes by Suppressing Th1 Development and Enhancing TolerogenicityDIABETESIF7.52013-05-17145OAAI
Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6CELL STEM CELLIF20.42009-07-011.6KOA